曼月樂與GnRH-α、口服避孕藥結(jié)合治療子宮腺肌癥的臨床分析

打開文本圖片集

【摘要】目的：探究分析在子宮腺肌癥患者中采取曼月樂分別與GnRH-α和口服避孕藥結(jié)合治療的效果。方法：選擇80例子宮腺肌癥患者為研究對(duì)象，采用隨機(jī)數(shù)字表法分為兩組。對(duì)比兩組臨床治療效果。結(jié)果：治療后，實(shí)驗(yàn)組患者子宮體積明顯小于對(duì)照組、月經(jīng)量明顯少于對(duì)照組、疼痛評(píng)分明顯低于對(duì)照組（P

【關(guān)鍵詞】曼月樂；GnRH-α；口服避孕藥；子宮腺肌癥

Clinical analysis of Mirena combined with GnRH-α and oral contraceptives in the treatment of adenomyosis

GUO Ming， HUANG Linghong

Red Star Hospital， 13th Division， Xinjiang Production and Construction Corps， Hami， Xinjiang 839000， China

【Abstract】Objective： To explore and analyze the effect of Mirena combined with GnRH-α and oral contraceptives in patients with adenomyosis. Methods： 80 patients with adenomyosis were selected as the research objects and divided into two groups by random number table method. The clinical treatment effects of the two groups were compared. Results： After treatment， the uterine volume of the experimental group was significantly smaller than that of the control group， the menstrual flow was significantly less than that of the control group， and the pain score was significantly lower than that of the control group（P

【Key Words】Mirena； GnRH-α； Oral contraceptives； Adenomyosis

子宮腺肌癥屬于子宮內(nèi)膜異位癥的一種，病灶主要生長(zhǎng)在子宮肌層內(nèi)，當(dāng)患者出現(xiàn)子宮腺肌癥后，會(huì)導(dǎo)致子宮體積增大、月經(jīng)量增加、經(jīng)期時(shí)間延長(zhǎng)、痛經(jīng)癥[1]。（剩余5014字）